Enanta Pharmaceuticals
ENTA
ENTA
122 hedge funds and large institutions have $454M invested in Enanta Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 45 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 126 → 122 (-4)
16% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 45
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Holders
122
Holding in Top 10
2
Calls
$1.29M
Puts
$1.05M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$5.1M | |
| 3 | +$3.27M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.58M |
| 5 |
First Manhattan
New York
|
+$2.02M |
Top Sellers
| 1 | -$8.07M | |
| 2 | -$3.6M | |
| 3 | -$3.53M | |
| 4 |
BlackRock
New York
|
-$3.48M |
| 5 |
MCM
Matarin Capital Management
New York
|
-$2.56M |